When things don’t seem to go their way, people often find it’s easier to ignore it, mutter frustrations under their breath, share thoughts with friends, and post opinions on social media. We have been there many times ourselves. But other…
Step aside, Multiple Sclerosis. You’re getting in Kathy Chester’s way. To say Kathy, who has had MS for 20+ years, is on the move is an understatement. She’s on a mission, and we recently caught up with her to chat…
Imagine if we all took the time to go beyond what’s comfortable. This is exactly what Jennifer did when she investigated whether multiple sclerosis is considered a rare disease. Turns out it is, and just like that, our disease-related community…
I have experienced firsthand the benefits of working remotely for nearly five years as a senior writer at Ruffalo Noel Levitz. This is why my former colleague Kristi DePaul – now the CEO of Founders – didn’t have to ask…
Dan and I often say that we are one in a million. This tongue-in-cheek statement loosely refers to the fact that there are nearly one million Americans living with Multiple Sclerosis, and each one of us is one of that…
We can’t say enough about Tyler Campbell and the impact he is having on us and members of the Multiple Sclerosis community. You need to hear him for yourself. We are so honored to share with you in this podcast…
When is the last time you weighed yourself? How did you do it? For most people, it’s a matter of stepping on a scale and looking at the number. But for Jennifer, who no longer can stand on her own,…
These three thoughts keep going through Jennifer’s mind after ever since Dan turned 50 in September: “Here we go again.” “If it is worth doing, it is worth doing again.” “Nothing worth having is easy to get.” Seeing Dan hitting…
We celebrated with the Multiple Sclerosis community as TG Therapeutics announced in the final days of 2022 that the FDA approved Briumvi (ublituximab-xiiy), putting the number of available MS disease-modifying therapies to more than 25. Hooray, right? Of course! But…
There is exciting research happening at the University of Pennsylvania addressing ways to slow Multiple Sclerosis progression through precision medicine. Dan and I had the opportunity last month to interact with a lead researcher on this project. We, along with…